INVO Fertility, Inc. has filed an 8-K revealing that on May 23, 2025, they entered into an agreement to divest 19.9% of their stake in NAYA Therapeutics by exchanging shares and issued a secured convertible promissory note for approximately $4.8 million; they also made amendments to preferred stock designations.